The Stocks Wall Street Is Watching

The following stocks may be
impacted due to significant news as noted:

Generic drug stocks look to be under selling
pressure at the open as Merrill Lynch downgrades Alergan
(
AGN |
Quote |
Chart |
News |
PowerRating)
,
Forest Labs

(
FRX |
Quote |
Chart |
News |
PowerRating)
, and Barr Labs
(
BRL |
Quote |
Chart |
News |
PowerRating)
to "neutral" from
"buy".

Media company New York Times
(
NYT |
Quote |
Chart |
News |
PowerRating)
has
issued a profit warning for its first-quarter, and now expects to earn
$0.42-0.45 per share vs. previous estimates of $0.44.

Gold miner Newmont Mining
(
NEM |
Quote |
Chart |
News |
PowerRating)
has beat
its fourth-quarter earnings by $0.02 with profits of $0.19 per share.

Biotech firm Invitrogen
(
IVGN |
Quote |
Chart |
News |
PowerRating)
has had
coverage initiated on it by Morgan Staley at "underweight".

Clothing retailer Jones Apparel
(
JNY |
Quote |
Chart |
News |
PowerRating)
has
been downgraded by Merrill Lynch to "neutral" from "buy".

Pre-market action:


(
FLML |
Quote |
Chart |
News |
PowerRating)
+13%,
(
MVSN |
Quote |
Chart |
News |
PowerRating)
-9%,
(
IMCL |
Quote |
Chart |
News |
PowerRating)
+7%,
(
FINL |
Quote |
Chart |
News |
PowerRating)
+4.3%,
(
RIMM |
Quote |
Chart |
News |
PowerRating)
+2.5%.


(
SWFT |
Quote |
Chart |
News |
PowerRating)
-7%,
(
KMT |
Quote |
Chart |
News |
PowerRating)
-7%,
(
TRDO |
Quote |
Chart |
News |
PowerRating)
-6.5%,
(
XMSR |
Quote |
Chart |
News |
PowerRating)

-4.5%,
(
NXTL |
Quote |
Chart |
News |
PowerRating)
-4%,
(
BRL |
Quote |
Chart |
News |
PowerRating)
-3.1%, 
(
FRX |
Quote |
Chart |
News |
PowerRating)
-2%.